Betulinic acid alleviates myocardial hypoxia/reoxygenation injury via inducing Nrf2/HO-1 and inhibiting p38 and JNK pathways
Authors:
- 1 November 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 838, 53-59
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Betulinic acid attenuates dexamethasone-induced oxidative damage through the JNK-P38 MAPK signaling pathway in miceBiomedicine & Pharmacotherapy, 2018
- Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathwayApoptosis, 2017
- Protective effect of betulinic acid on early atherosclerosis in diabetic apolipoprotein-E gene knockout miceEuropean Journal of Pharmacology, 2017
- Betulinic acid protects against cerebral ischemia/reperfusion injury by activating the PI3K/Akt signaling pathwayBiomedicine & Pharmacotherapy, 2016
- Pathophysiology of Acute Coronary SyndromeCurrent Atherosclerosis Reports, 2014
- Betulinic acid ameliorates endothelium-dependent relaxation in l-NAME-induced hypertensive rats by reducing oxidative stressEuropean Journal of Pharmaceutical Sciences, 2011
- Protective role of betulinic acid on TNF-α-induced cell adhesion molecules in vascular endothelial cellsBiochemical and Biophysical Research Communications, 2010
- Nrf2:INrf2 (Keap1) signaling in oxidative stressFree Radical Biology and Medicine, 2009
- Betulinic acid protects against ischemia/reperfusion‐induced renal damage and inhibits leukocyte apoptosisPhytotherapy Research, 2009
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007